Please login to the form below

Not currently logged in

Hume Brophy launches new life science division

Will provide a targeted approach to healthcare communications

Hume BrophyPublic and corporate affairs agency Hume Brophy has launched a new life sciences arm to its international healthcare business.

Hume Brophy Life Sciences will provide a targeted approach to healthcare communications and further help their clients navigate “highly-regulated complexities of the vibrant life science market across Europe”.

Drawing in ‘experts’ from across the medical communications, science, academia, media, pharma and biotech fields, the team will develop and deliver advocacy platforms, strategic communications and market planning programmes.

The new practice will be led by Hume Brophy International Healthcare’s managing director Conor Griffin.

He said: “In an increasingly competitive, fast-changing and cost-sensitive healthcare industry we have put together a multidisciplinary team of science, media, regulatory and policy experts that can translate the complex challenges facing healthcare innovators into tailored strategic communication programmes to highlight the often unmet needs for an increasingly demanding society.”

The practice will operate from all Hume Brophy offices, including London, Brussels, Dublin, New York, Paris, Hong Kong and Singapore.

Article by
Gemma Jones

1st March 2018

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Lucid Group Communications Limited

We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...